StockNews.com downgraded shares of Prestige Consumer Healthcare (NYSE:PBH – Free Report) from a strong-buy rating to a buy rating in a report issued on Tuesday morning. Other research analysts have also recently issued reports about the stock. DA Davidson reaffirmed a neutral rating and set a $65.00 target price on shares of Prestige Consumer Healthcare […]